Tag: medicare

R3 Vascular

R3 Vascular secures WCG IRB approval and CMS category B Medicare...

R3 Vascular today announced that it has received WCG Institutional Review Board (IRB) approval for the ELITE-BTK pivotal trial of its Magnitude drug-eluting next-generation...

CMS carotid stenting coverage expansion initiates concern over standard-of-care requirements and...

Dated 11 October 2023, the US Centers for Medicare & Medicaid Services (CMS) recently finalised its decision regarding National Coverage Determination (NCD) 20.7 for...

CMS confirms broadened Medicare coverage of carotid stenting in final decision...

The Centers for Medicare & Medicaid Services (CMS) has released its final decision regarding National Coverage Determination (NCD) 20.7 covering carotid artery stenting (CAS),...

VLF 2019: Real world data provide glimpse into peripheral drug-eluting devices...

 Eric Secemsky (Boston, USA) takes Interventional News through the main highlights of his recently published analyses of a US Medicare claims dataset that examined...

New CMS reimbursement code “severely underpays” for drug-coated balloons

Drug-coated balloon (DCB) angioplasty devices have been categorised by the US Centers for Medicare and Medicaid Services (CMS) into the same billing code as...